Cough after non-small cell lung thoracoscopic pneumonectomy
Conditions
Interventions
Control group:Placebo
Sponsors
Peking University people's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients who underwent thoracoscopic sublobe, lobe, compound lobe or pneumonectomy, with or without mediastinal lymph node resection; 2. The postoperative pathological diagnosis was primary non-small cell lung cancer stage I, stage II or carcinoma in situ; 3. Meet the diagnosis of postoperative cough and cough occurs within one month after surgery; 4. It conforms to the syndrome differentiation criteria of wind evil invading the lung and lung qi losing circulation; 5. Aged 18-65 years old male or female; 6. Day cough symptom score >=2 points and/or night cough symptom score >=2 points; 7. Voluntary participation in the clinical trial, informed consent and signature of informed consent.
Exclusion criteria
Exclusion criteria: 1. Cough not caused by early postoperative non-small cell lung cancer; 2. Those who meet the diagnostic criteria for non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, or targeted therapy; 3. Those who have a history of allergies to the composition of Suhuang Zhike Capsule; 4. Those who are participating in other clinical trials within 4 weeks before enrollment 5. Cough caused by bronchitis; 6. Patients who have had a cough before thoracoscopic pneumonectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LCQ;Renal function;TCM Syndrome Score Table;Routine urine examination;Routine stool test;Routine blood test;Chest X-ray examination;12-lead electrocardiogram;Cough Symptom Score Table;Liver function; | — |
Countries
China
Contacts
Public ContactCuiling Feng
Peking University People's Hospital
Outcome results
None listed